Cargando…
Peripheral Blood Serum NMR Metabolomics Is a Powerful Tool to Discriminate Benign and Malignant Ovarian Tumors
Ovarian cancer is the major cause of death from gynecological cancer and the third most common gynecological malignancy worldwide. Despite a slight improvement in the overall survival of ovarian carcinoma patients in recent decades, the cure rate has not improved. This is mainly due to late diagnosi...
Autores principales: | Nunes, Sofia C., Sousa, Joana, Silva, Fernanda, Silveira, Margarida, Guimarães, António, Serpa, Jacinta, Félix, Ana, Gonçalves, Luís G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537270/ https://www.ncbi.nlm.nih.gov/pubmed/37755269 http://dx.doi.org/10.3390/metabo13090989 |
Ejemplares similares
-
Glutathione in Ovarian Cancer: A Double-Edged Sword
por: Nunes, Sofia C., et al.
Publicado: (2018) -
Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
por: Nunes, Sofia C., et al.
Publicado: (2018) -
NMR Metabolomics for Stem Cell type discrimination
por: Castiglione, Franca, et al.
Publicado: (2017) -
Cysteine Boosts Fitness Under Hypoxia-Mimicked Conditions in Ovarian Cancer by Metabolic Reprogramming
por: Nunes, Sofia C., et al.
Publicado: (2021) -
A Metabolomics-Inspired Strategy for the Identification of Protein Covalent Modifications
por: Nunes, João, et al.
Publicado: (2019)